Gregory Glover is a principal and non-practicing physician with Pharmaceutical Law Group. A registered patent attorney, he is an expert on the complex interaction of food and drug laws and intellectual property. Glover represents life sciences companies, investors, and trade associations on strategic product development issues. He has testified on behalf of the research-based pharmaceutical industry before congressional committees on legislative matters affecting market protection for pharmaceutical, biotechnology, and medical device products, and he has made presentations on behalf of research-based companies on market protection issues before the Food and Drug Administration, the Federal Trade Commission, and the Department of Justice.
Previously
High drug prices have seized headlines, angered patient advocates, and prompted congressional hearings. Many causes have been suggested — among them, a fragmented pharmaceutic...